The Exchange has sought clarification from Aerpace Industries Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

The Exchange has sought clarification from Anna Infrastructures Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

The Exchange has sought clarification from Atul Ltd on December 16, 2025, with reference to Movement in Volume. The reply is awaited.

Clarification with respect to Outcome of Board Meeting dated September 05, 2025.

Inter alia: 1. Discussed and approved appointment of Mr. Prashant Kamat (DIN: 07212749) as an Additional Director under Non- Executive Non-Independent Category of the Company with effect from January 1, 2026, and approved his regularization as Director, subject to approval of Members of the Company. 2. Accepted the resignation of Mr. Surej Kunhithayyil Poyil (DIN: 10999955) tendered by him vide letter dated December 15, 2025, from the post of the Non-Executive Non- Independent Director and CEO Designate of the Company with effect from December 16, 2025, in order to completely focus on the International operations of the wholly owned subsidiary, Technology Associates Inc; (TA Inc) USA as he continues to be Chief Executive Officer of TA Inc. 3. Approved change in designation of Mr. Sagar Meghe (DIN 00127487) from Non- Executive NonIndependent Director-cum-Chairman to Whole Time Director and Chairman of the Company with effect from December 16, 2025, and fixed his remuneration and terms of appointment, subject to approval of Members of the Company. (Refer Annexure 4). The Board appreciated Mr. Sagar Meghe for taking over the Executive position and expressed their optimism of the company scaling even greater heights with his able active guidance

The Exchange has sought clarification from Concord Enviro Systems Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

The Exchange has sought clarification from Coromandel Engineering Company Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

Inter alia, considered and approved the following:- 1. Proposal to change name of the Company from ?Deep Diamond India Limited? to either ?Deep Health India Limited? or ?Deep Health AI India Limited? or such other name as may be approved by the Registrar of Companies, upon the approval of the Central Registration Centre (?CRC?), Ministry of Corporate Affairs (?MCA?) and other relevant authority(ies), if any, and consequent Alteration of the relevant clauses of Memorandum of Association and Articles of Association of the Company pursuant to name change, subject to the approval of members. 2. The variation in the objects and utilisation of proceeds thereof, and rati?ication of the deviations to the extent already undertaken, in respect of the Rights Issue offered to the eligible equity shareholders of the Company, as allotted by the Right Issue Committee of the Company on October 06,2025 , subject to the approval of the shareholders of the Company. 3. Considered and approved the draft postal ballot notice for seeking approval of Shareholders amongst other agendas for the proposal of : (i) Proposal to obtain the approval of shareholders to change the name of the Company from ?Deep Diamond India Limited? to either ?Deep Health India Limited? or ?Deep Health AI India Limited? or such other name as may be approved by the Registrar of Companies, upon the approval of the Central Registration Centre (?CRC?), Ministry of Corporate Affairs (?MCA?) and other relevant authority(ies), if any, and consequent Alteration of the relevant clauses of Memorandum of Association and Articles of Association of the Company pursuant to name change. (ii) obtaining approval shareholders of the Company for variation in the objects and utilisation of proceeds thereof, and rati?ication of the deviations to the extent already undertaken, in respect of the Rights Issue offered to the eligible equity shareholders of the Company, as allotted by the Right Issue Committee of the Company on October 06,2025.

The Exchange has sought clarification from Digjam Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

Inter alia, considered the following:- 1. Based on the recommendaOon of NominaOon and RemuneraOon Commi?ee of the Company, the Board has approved the appointment of Mr. Suresh Kumar Gupta (DIN: 00375710) as an AddiOonal Director in the category of Non- ExecuOve Independent Director of the Company for a term of 5 (five) consecuOve years commencing from December 16, 2025, subject to the approval of the shareholders of the Company. Further, as per the requirement of the Circular No. LlST/COMP/14/2018-19 dated June 20, 2018 issued by the BSE, we hereby confirm that he is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other such authority. 2. The Board has approved the acquisiOon of 50.10 % stake in Solluz Energy Private Limited (?Solluz?) having CIN: U52100DL2015PTC277648 and decided to enter into the Share SubscripOon Agreement. Consequently, Solluz will become the Subsidiary of the Company 3. The Board has approved the re-consOtuOon of various commi?ees of Board of Directors of the Compan

Inter alia, approved:- 1. Re-appointment of Mr. Darshil Hemendrakumar Shah (DIN: 09013533) and Mr. Nigambhai Govindbhai Sathavara (DIN: 09016786) as Non-Executive Independent Director of the Company for a 2nd term of 5 years with effect from 01st January 2026, subject to approval of the shareholders through Postal Ballot. 2. To approve the draft Postal Ballot Notice and Explanatory Statement. 3. Appointment of M/s Aanal Satyawadi & Co. Practicing Company Secretary of Scrutinizer for conducting the Postal Ballot process. 4. Approval of e-voting facility through NSDL for Postal Ballot.

Pursuant to the provision of Regulations 30 of SEBI (LODR) Regulations, 2015, the Company has received an Public Announcement dated December 15, 2025 in relation to open offer to the public shareholders of the Company.

The Exchange has sought clarification from Jai Balaji Industries Ltd on December 16, 2025, with reference to Movement in Volume. The reply is awaited.

The Exchange has sought clarification from Maha Rashtra Apex Corporation Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

The Exchange has sought clarification from Mansi Finance (Chennai) Ltd on December 16, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

The Exchange has sought clarification from Nuvoco Vistas Corporation Ltd on December 16, 2025, with reference to Movement in Volume. The reply is awaited.

Scheme of Arrangement Inter-alia, considered and approved: 1. the proposed scheme of arrangement amongst RACE ECOCHAIN LIMITED (herein after referred to as ?RACE/ Demerged Company? ) and GEOECO GREEN ENERGY LIMITED (herein after referred to as ?GEOECO/ Resultant Company No. 1) and RACE GATEWAY LIMITED (herein after referred to as ?GATEWAY/ Resultant Company No. 2) and the respective shareholders and creditors pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.the rules and/or regulations made thereunder (as amended from time to time) ("Companies Act"), Section 2(19AA) read with other relevant provisions of the Income TaxAct,1961(as amended from time to time) ("IT Act"). 2. Took Note of the resignation of Mr. Anil Kumar Behl (DIN: 00697588) as an Independent Director of the Company. 3. Change in designation of Mr. Anil Kumar Behl from Non-Executive Independent Director to NonExecutive Non Independent Director of the Company. 4. Re-constitution of Audit Committee of the Board as detailed below: 4.1 Appointment of Mr. Sanjay Kukreja (DIN: 08506956) as the Chairperson of the Audit Committee in place of Mr. Anil Kumar Behl with an immediate effect i.e. from 15th December, 2025. However Mr. Anil Kumar Behl will continue to serve as member of the Audit Committee. (see Company announcement on bse website: www.bseindia.com for details) 5. The shifting of Corporate Office (where Books of Account will be maintained) from56/33,Site-IV Industrial Area Sahibabad, Ghaziabad, Uttar Pradesh, India, 201010 to A- 115, Sector 136, Noida, Uttar Pradesh, India- 201304

General Inter- alia, considered and approved the following: 1. Appointment of Ms. Rekha Rathore as the Company Secretary and Compliance Officer of the Company and Key Managerial Personnel with effect from December 16, 2025. 2. Approved the appointment of Mr. Sudhindra Seth, as Internal Auditor of the Company for the Financial Year 2025-26, in compliance with Section 138 of the Companies Act, 2013 and the rules made thereunder

Scheme of Arrangement Inter alia, has approved the execution of the following documents: (i) the Investment Agreement (?IA?) amongst the Company, Bhansali Productions Private Limited (?BPPL?) and Sanjay Navin Bhansali, which sets out the terms and conditions of (a) subscription of 9,960 number compulsory convertible preference shares (?CCPS?) by the Company in BPPL for a consideration of INR 325 Crores and the terms of conversion of such CCPS; and (b) further acquisition of additional equity securities of BPPL in multiple tranches for a monetary consideration to be determined (?Proposed Transaction?); the relevant details of such further acquisition of equity securities of BPPL are set out in ?Annexure- A? below; (ii) the Shareholders Agreement (?SHA?) amongst the Company, BPPL and Sanjay Navin Bhansali, to set out their inter se rights and obligation as shareholders in BPPL; (iii) the Music Rights Agreement (?MRA?) between the Company and BPPL to set out the terms and conditions of acquisition of ownership of all BPPL?s rights in the music created and produced by BPPL; and (iv) other ancillary agreement to give effect to the Proposed Transaction the terms, contained under the Transaction Agreements (as defined hereinafter). This strategic investment in BPPL further reinforces the Company?s leadership in the Music Licensing business and expands its presence in the Video business.

Increase in Authorised Capital Inter alia, has considered and approved the following matters: 1. Allotment of equity shares Approved the allotment of 18,19,21,827 equity shares of Sequent having face value of Rs. 2 (Rupees Two) each to the shareholders of Viyash as on the Record Date 2 (i.e., December 8, 2025), pursuant to the Scheme as per the Share Exchange Ratio 2, which is as follows: Share Exchange Ratio 2: 56 (Fifty-Six) equity shares of Sequent of Rs. 2/- each fully paid up for every 100 (One Hundred) equity shares of Viyash of Rs. 10/- each fully paid up. Consequent to the allotment of the aforesaid equity shares, the issued and the paid-up equity share capital of the Company will increase from Rs. 50,82,25,298 (Rupees Fifty Crore Eighty Two Lakh Twenty Five Thousand Two Hundred and Ninety Eight only) consisting of 25,41,12,649 equity shares of Rs. 2 each to Rs. 87,20,68,952 (Eighty Seven Crore Twenty Lakh Sixty Eight Thousand Nine Hundred and Fifty Two Only) consisting of 43,60,34,476 equity shares of Rs. 2 each. The said equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Equity shares as allotted by Sequent shall also be listed on the BSE Limited and National Stock Exchange of India Limited as provided in the Scheme in due course. 2. Allotment of warrants Approved allotment of 2,03,41,257 (Two Crore Three Lakhs Forty-One Thousand Two Hundred and Fifty Seven) share warrants of the Company to the warrant holder of Viyash, in terms of the Scheme at an issue price per share warrant of Rs. 181.94 (Rupees One Hundred Eighty One and Ninety Four paise) determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 under the Scheme, as per the Warrant Exchange Ratio, which is as follows: Warrant Exchange Ratio: 56 (Fifty-Six) warrants of Sequent for every 100 (One Hundred) warrants of Viyash. Sequent has received 25% of the issue price per warrant i.e. Rs. 181.94 per share warrant as upfront payment aggregating to Rs. 92,52,22,075 for allotment of 2,03,41,257 (Two Crore Three Lakhs Forty-One Thousand Two Hundred and Fifty Seven) share warrants of the Company as per the terms of the Scheme Each share warrant shall be convertible into 1 (one) equity share of Sequent of Rs. 2 each in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, subject to receipt of balance consideration of Rs. 2,77,56,66,224 (being 75% of the issue price per warrant) from the allottee to exercise conversion option against each such share warrant. The other terms and conditions of the said warrants shall be as per applicable laws. 3. Changes in management In furtherance of our disclosure dated August 8, 2025, and pursuant to the effectiveness of the Scheme, the board of directors has: (a) Approved appointment of Dr. Haribabu Bodepudi (DIN:01119687) as the Managing Director and Group Chief Executive Officer of the Company for a period of 2 consecutive years w.e.f. December 16, 2025, subject to shareholders approval. (b) Approved change in designation of Mr. Rajaram Narayanan (DIN: 02977405) to Wholetime director designated as Chief Executive Officer ? Animal Health of the Company for the remaining period of his existing tenure w.e.f. December 16, 2025, subject to shareholders approval. (c) Approved appointment of Mr. Srinivas Vasireddy (DIN:09771153) as an Additional Director (Wholetime and Non-Independent) of the Company for a period of 2 consecutive years w.e.f. December 16, 2025, subject to shareholders approval. (d) Approved appointment of Mr. Ramakant Singani as Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. January 1, 2026. (e) Noted resignation of Mr. Saurav Bhala as Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. January 01, 2026. The Company places on record its deep sense of appreciation for the services rendered by him and for his contributions to the company. A copy of the resignation letter is enclosed as Annexure 5A. 4. Other matters noted pursuant to and consequential to the Scheme Noted other matters and actions that occurred in connection with the effectiveness of the Scheme, including: (a) CA Hull Investments becoming a promoter of Sequent with effect from the Effective Date 2 pursuant to effectiveness of the Scheme and the consequent allotment of equity shares of Sequent to CA Hull, in accordance with and as contemplated under the Scheme; (b) Replacement of Clause V of the Memorandum of Association of Sequent regarding the authorised share capital with the following: ?The Authorised Share Capital of the Company is Rs. 8,86,14,70,000 (Rupees Eight Hundred Eighty Six Crore Fourteen Lakh Seventy Thousand) divided into 4,43,07,35,000 (Four Hundred Forty Three Crore Seven Lakh Thirty Five Thousand) equity shares of Rs. 2 (Rupees Two Only) each with power to increase and/ or reduce the capital, to divide the shares in the capital for the time being into several classes and to attach thereto respectively such qualified or special rights or privileges or conditions as may be determined by or in accordance with the regulations of the Company and to vary, or modify or abrogate any such rights, privileges or conditions in such manner as may from the time being be provided by the regulations of the Company and to consolidate or sub-divide the shares and issue shares of higher or lower denominations.? (c) Replacement of Article No. 5 of the Articles of Association of the Sequent regarding the authorised share capital shall, with the following: ?The Authorised Share Capital of the Company is Rs. 8,86,14,70,000 (Rupees Eight Hundred Eighty Six Crore Fourteen Lakh Seventy Thousand) divided into 4,43,07,35,000 (Four Hundred Forty Three Crore Seven Lakh Thirty Five Thousand) equity shares of Rs. 2 (Rupees Two Only) each. The Company has power from time to time to increase or reduce its capital. Any of the said shares and any news shares thereafter to be created may from time to time be divided into shares of several classes in such manner as may be provided hereinafter and the Company may allow and so that the shares of each class may have or confer such preferred or other special rights and privileges as may be issued under such restrictions and conditions whether in regard to dividend, voting, return of capital or otherwise as shall have been assigned thereto by or under the provisions of the Articles of Association but so that the special rights or privileges belonging to holders of any shares issued with preferred or other rights shall not be varied or abrogated or affected except with sanction as is provided for hereafter.? (d) Noted the cessation of Sequent Research Limited as a wholly owned subsidiary of the Company pursuant to its amalgamation with the Company under the Scheme, and Appco Pharma LLC becoming a material subsidiary of the Company upon transfer of all assets and liabilities of Viyash into Sequent under the Scheme with effect from the Effective Date 2.